Pandemic paradox: How the COVID-19 crisis transformed vaccine hesitancy into a two-edged sword

ABSTRACT

The rapid development of COVID-19 vaccines was a landmark achievement that saved millions of lives. However, this success also intensified vaccine hesitancy, as misinformation, evolving public health guidelines, and growing distrust in institutions fueled anti-vaccine sentiment. In this opinion piece, we explore the paradoxical legacy of the COVID-19 vaccination campaign – how a global scientific triumph simultaneously gave rise to an emboldened anti-vaccine movement. Drawing on international data, we highlight the association between baseline vaccine acceptance and subsequent booster uptake and interpret these trends through the lens of the Health Belief Model. We further examine the psychological, cultural, political, and structural drivers of hesitancy and outline key strategies to rebuild public trust. Addressing this crisis requires proactive, evidence-informed, and culturally sensitive approaches to safeguard the future of global immunization efforts.

Introduction

The COVID-19 pandemic marked an unprecedented moment in history where global scientific collaboration enabled the rapid development of vaccines to combat a deadly virus. Initially, the sense of urgency, fear, and high mortality rates pushed countries and individuals to embrace vaccination as a solution.¹ However, this success story simultaneously laid the foundation for what is now an emboldened anti-vaccine movement and increased vaccine hesitancy.

This paradox arises from the very nature of the COVID-19 crisis: while vaccines were instrumental in saving millions of lives. However, evolving public health guidelines, widespread misinformation, and societal distrust undermined public acceptance (Figure 1). Understanding the dual impact of this pandemic is critical to addressing vaccine hesitancy and preventing the resurgence of preventable diseases.

Figure 1.

Positive and negative edge of COVID-19 vaccination.

Methodology

To evaluate whether baseline vaccine acceptance correlates with subsequent booster uptake, we classified countries into two groups based on acceptance rates reported in the global cross-sectional survey by Lazarus et al. (2023),² conducted between June 29 and July 10, 2022. Countries with ≥75% COVID-19 vaccine acceptance were categorized as High Acceptance, while those with <75% were labeled Low Acceptance. This threshold aligns with the survey’s reported global average and provides a meaningful dichotomy for comparative analysis.

We retrieved the most up-to-date cumulative data on initial and booster COVID-19 vaccine doses (as of July 2025) from Our World in Data. For each country, we calculated the proportion of booster doses relative to initial doses administered. These ratios served as a proxy for booster uptake performance within each group.

To test for statistically significant differences in booster uptake between high and low acceptance countries, we performed an independent samples t-test comparing the means of booster-to-initial dose ratios across the two groups. This approach was preferred over a two-proportion z-test given the continuous nature of our ratio variable and the unequal group sizes. The resulting p-value (p < .0001) confirmed a significant difference in booster uptake favoring countries with higher initial vaccine acceptance.

This method allowed us to empirically assess whether populations more receptive to initial vaccination efforts maintained higher adherence to booster campaigns.

Results

Countries classified as having high vaccine acceptance had a significantly higher mean booster uptake (39.56%) compared to those with low acceptance (24.99%). The difference was statistically significant (p < .0001), suggesting that higher initial acceptance of COVID-19 vaccines is positively associated with subsequent uptake of booster doses. This relationship is visually represented in Figure 2, which shows the distribution of booster uptake percentages by group.

Figure 2.

Booster uptake by COVID-19 vaccine acceptance level.

Achievements and challenges in COVID-19 vaccination efforts

The pandemic demonstrated the extraordinary potential of modern science and innovation. Vaccines were developed and approved at unprecedented speed, leveraging platforms like mRNA technology. This marked a breakthrough not just for COVID-19 but for other diseases requiring novel immunization strategies.

• – Reduction of Severe Illness and Death: Early data showed that COVID-19 vaccines significantly reduced hospitalizations and mortality. Countries with high vaccination rates saw faster recoveries from pandemic waves compared to regions with lower uptake.³

• – Building Global Infrastructure: Investments in vaccine development and production infrastructure have paved the way for better preparedness for future pandemics.

• – Raising Awareness of Vaccination: The pandemic created a global platform that emphasized the importance of vaccines as a public health tool, drawing increased public and political attention to immunization programs.

Yet, as the pandemic progressed, this early optimism faced significant resistance, resulting in a surge of vaccine hesitancy.

Vaccine hesitancy and the anti-vaccine movement

The COVID-19 pandemic, rather than silencing anti-vaccine activism, amplified its reach and influence. Contributing factors included misinformation, institutional distrust, cultural attitudes, and socio-political dynamics.

Our discussion of vaccine hesitancy is grounded in the Health Belief Model (HBM), a theoretical framework widely applied in health behavior research.⁴ According to the HBM, individuals’ decisions to accept or reject vaccination are influenced by their perceived susceptibility to and severity of disease, perceived benefits and barriers of vaccination, external cues to action, and self-efficacy. This model provides a structured lens through which we examine the psychological, cultural, social, and political factors that shaped vaccine attitudes during and after the COVID-19 pandemic.

Misinformation and social media amplification

Social media platforms served as double-edged swords – enabling the rapid dissemination of credible scientific information while simultaneously amplifying misinformation.

• – Influential users, including anti-vaccine activists, exploited platforms like Facebook and Twitter to spread conspiracy theories questioning vaccine safety, claiming that vaccines altered human genetics, or suggesting that COVID-19 vaccines were tools for population control.^5,6

• – A study analyzing 100,601 tweets related to COVID-19 vaccine conspiracy theories found that these tweets significantly influenced public discourse and were more likely to be shared. Another study analyzing 8,500 Twitter users showed that only 12.7% of malicious accounts disseminating harmful content were suspended.^7,8

• -Kalichman et al., in their analysis of 2,060 Facebook posts, found that early anti-vaccine disinformation campaigns outperformed public health messaging and disrupted COVID-19 vaccine distribution.⁹

• -The overabundance of information about COVID-19 vaccines on social media has also been shown to generate fear and increase distrust, especially among vulnerable groups.¹⁰

• -Misinformation often outpaced corrective efforts, contributing to widespread fear of side effects, mistrust in healthcare systems, and increased vaccine hesitancy.^9,11

Erosion of public trust

Trust in health authorities and institutions deteriorated during the pandemic.

• – Mixed messaging regarding booster doses and evolving scientific guidelines created confusion. While this reflected the real-time learning process of a novel virus, it was misinterpreted as evidence of incompetence or conspiracy.

• – Studies have shown that among individuals who expressed trust in their local healthcare systems, 38.4% were willing to get vaccinated, compared to just 23.5% among those who lacked such trust.¹²

• – Skepticism regarding the pharmaceutical industry’s motivations – often tied to political narratives – further exacerbated public distrust.^13,14

Cultural and socioeconomic factors

Vaccine hesitancy has been shaped by local contexts, further complicating global immunization efforts.

• – Socioeconomic Barriers: In Sri Lanka, hesitancy was linked to a reliance on traditional medicine and fear of vaccine side effects.¹⁵ In Ethiopia, socioeconomic status significantly influenced vaccine uptake; measles vaccination was more common among children from wealthier households. A similar pattern was observed with the rotavirus vaccine, which was more accepted in families with higher socioeconomic status.^16,17 A study from Greater Manchester found that influenza vaccine uptake increased in less disadvantaged areas post-pandemic, while rates remained stagnant or declined in more disadvantaged areas.¹⁸ In China, individuals with higher income levels were more likely to receive the hepatitis B vaccine, while low income and lack of disease awareness were key barriers.¹⁹ COVID-19 vaccine uptake was lower among socioeconomically disadvantaged populations in Belgium and higher in U.S. counties with greater socioeconomic resources.^20,21

• – Religious Beliefs: Vaccine hesitancy in some communities has been linked to religious objections based on misconceptions about vaccine ingredients or development processes.²² For example, among Muslim populations, concerns include the presence of porcine or non-halal substances and conflicts with Ramadan observance. Amish and Catholic groups have rejected vaccines over the use of fetal cell lines, while some Christian communities associate the HPV vaccine with sexual promiscuity.²³

• – Political Divisions: In regions like the United States, vaccine attitudes became increasingly polarized, with conservative groups framing mandates as infringements on personal freedom.²⁴ Political distrust has been identified as a significant factor in vaccine hesitancy.²⁵ Mesch and Schwirian found that Americans with higher trust in government were significantly more likely to be vaccinated (43.4%) compared to those with lower trust (15.8%).¹² In Tanzania, inconsistent messaging from political and community leaders contributed to vaccine skepticism, with some people questioning the existence of the virus and the vaccine itself.²⁶

Power structures

Corruption in healthcare systems and governments regarding vaccine acquisition and distribution – combined with inconsistent delivery – has undermined public trust. A lack of agency and local control over international health interventions has further exacerbated feelings of marginalization and neglect.²⁷

Moreover, perceptions that international actors and domestic elites profited from the crisis, coupled with prior experiences of exploitation, unethical research, and systemic exclusion, have fueled deep mistrust in vaccines and public health systems.²⁷

Reconstituting the advisory committee for immunization practices (ACIP) and controversial statements

Health Secretary Robert F. Kennedy Jr. dismissed all 17 sitting members of the ACIP and appointed new individuals, including a researcher critical of vaccine safety, an epidemiologist who opposed pandemic lockdowns, and a nurse known for anti-vaccine views.^28,29

This unprecedented reorganization occurred on June 9, 2025, and has been widely criticized by scientific and medical associations, including the National Foundation for Infectious Diseases (NFID), for undermining public trust. Following this event, a July 2025 survey by the Kaiser Family Foundation (KFF) reported that parental skepticism toward vaccines rose from 22% to 27%, citing perceived politicization as a primary concern.³⁰ Experts warned that replacing experienced members with individuals holding fringe views on vaccine safety may delay the issuance of evidence-based recommendations and contribute to greater public confusion and reduced adherence.²⁸

In recent outbreaks, the Health Secretary made scientifically unsupported claims that went against vaccination, such as asserting that the effectiveness of the MMR (measles, mumps, and rubella) vaccine declines rapidly.³¹ Those statements, particularly from public health authorities, can reinforce existing vaccine hesitancy. Nuermi and Jaakkola noted that some parents avoid vaccinating their children due to fear that, if adverse events occur, the responsibility will fall solely on them.³²

Psychological and behavioral factors

Psychological variables have also played a key role in vaccine hesitancy. Psychological distress can reduce willingness to vaccinate by fostering belief in conspiracy theories and increasing institutional distrust.³³ Kim et al. found that individuals with high scores on the GAD-7 and Illness Attitude Scale were more likely to exhibit vaccine hesitancy.³⁴ Similarly, death anxiety has been linked to reduced vaccination through a pathway mediated by conspiratorial thinking, while paranoia has been associated with lower vaccine adherence via diminished trust in medical science.³³

Fear also plays a paradoxical role. Nazli et al. observed that individuals with lower levels of COVID-19-related fear were significantly more likely to delay or reject vaccination (p < .05).³⁵ Vaccine rejection may stem from a belief that public health guidance infringes upon personal autonomy.³⁶ Additional psychological predictors include reduced interoceptive awareness, diminished cognitive empathy, poor executive functioning,³⁷ and elevated stress levels – all of which have been linked to greater hesitancy in the post-pandemic context.³⁸

The long-term impact: an escalating crisis

The consequences of the antivaccine movement are profound and far-reaching:

• – Delayed Herd Immunity: Persistent vaccine hesitancy has delayed progress toward herd immunity, allowing SARS-CoV-2 to remain endemic in many regions.

•     Delayed vaccination increases the likelihood of outbreaks of preventable diseases.³⁹ In diseases like measles, herd immunity has been shown to reduce transmission significantly. For SARS-CoV-2, the accumulation of immune individuals contributes to endemic equilibrium, offering indirect protection to the unvaccinated.⁴⁰

• – Emergence of Variants: Prolonged viral circulation in under vaccinated populations has facilitated the evolution of new variants, undermining vaccine efficacy and pro-longing the pandemic.^11,13

•    As in the case of Omicron, which emerged in regions with the lowest vaccination rates, it is known that the emergence of new variants in regions with low vaccination coverage reflects uncontrolled viral  replication in unprotected populations.⁴¹ Additionally, the emergence of new variants can lead to immune resistance against current vaccines.⁴²

• –  Spillover to Routine Immunization Programs:

The distrust fostered during the COVID-19 pandemic has extended to routine childhood immunizations, raising the alarming possibility of resurgences of diseases such as measles, diphtheria, and polio – conditions that had been largely controlled for decades.^14,15 This concern is no longer hypothetical. As of July 15, 2025, the U.S. Centers for Disease Control and Prevention (CDC) reported 1,309 confirmed measles cases across 40 jurisdictions, marking the highest national total since the disease was declared eliminated in 2000. Of these cases, 1,151 (88%) were associated with 29 distinct outbreaks, primarily affecting unvaccinated communities. This surge coincides with a decline in MMR vaccine coverage among U.S. kindergartners, which dropped from 95.2% in 2019–2020 to 92.7% in 2023–2024 leaving more than 280,000 children susceptible to infection.⁴³

Public perception has also shifted: a June 2025 Harvard T.H. Chan School of Public Health poll revealed that support for routine childhood vaccine requirements declined to 79%, down from 85% in 2019. While the majority still believe vaccines are effective and important for public health, growing opposition is increasingly framed around parental autonomy rather than concerns about safety.⁴⁴ Notably, more than 40% reported having changed their views on vaccination in the past five years, often citing growing institutional distrust. These findings echo global trends. A review of public health data indicates significant declines in routine vaccination rates across both high- and low-income countries during the pandemic, underscoring the urgent need for comprehensive catch-up immunization campaigns to prevent further erosion of herd immunity and the resurgence of vaccine-preventable diseases.^22,45

Combating vaccine hesitancy: strategies for the future

Addressing this two-edged crisis requires a coordinated, evidence-based approach focused on rebuilding public trust and effectively countering misinformation. The following strategies have demonstrated effectiveness:

Strengthening communication efforts

• – Public health agencies must adopt clear, consistent messaging to address uncertainties. Efforts should focus on prebunking misinformation before it takes hold, rather than reactive debunking.

• – Collaborative campaigns involving trusted messengers – such as community leaders, healthcare professionals, and faith-based organizations – can help bridge cultural and social divides.

Iannizzi et al. demonstrated that education and information strategies significantly improved vaccine uptake (RR: 1.23; 95% CI: 1.17–1.28; high-certainty evidence), as did messaging that emphasized prevailing social norms (RR: 1.28; 95% CI: 1.23–1.33; high-certainty evidence).⁴⁶ Visual resources and materials that clearly present both the benefits and potential risks of vaccination further enhance message credibility and impact.⁴⁷

Addressing social media misinformation

• – Technology companies must be held accountable for the unchecked spread of vaccine-related misinformation. Effective policies should include flagging false content, promoting verified, evidence-based information, and penalizing repeat offenders.

• – Targeted campaigns such as One Vax Two Lives have successfully used social media strategies to address vaccine hesitancy among pregnant individuals.²⁴

Bautista et al. found that fact-checked corrections on social media increased willingness to vaccinate, especially among individuals with moderate to high levels of skepticism – provided the information was perceived as trustworthy.⁴⁸ Similarly, Jheng et al. reported that corrective texts addressing COVID-19 vaccine misinformation significantly reduced public misconceptions.⁴⁹

Normalizing booster doses

Public health messaging should frame COVID-19 booster doses similarly to routine immunizations, such as the annual influenza vaccine. This approach may help reduce resistance and promote acceptance of boosters as part of ongoing preventive care.

Text message reminders that incorporate personalization have been shown to increase vaccine uptake. Additionally, sending a second reminder – regardless of the message content – further enhanced acceptance.⁵⁰

Improving global equity

• – Improving vaccine access and distribution in underserved regions is essential to reducing disparities and maximizing the global impact of immunization.

• – Initiatives such as COVAX were designed to close the vaccine gap between high-income and low- and middle-income countries.⁵¹

• – An analysis of the number of COVID-19 vaccine doses allocated by COVAX to 88 funded countries and data from 60 self-financing countries supported by COVAX revealed that by early 2022, a total of 1,678,517,990 vaccine doses had been allocated. Of these, 61% had been distributed to 148 countries, and countries with lower gross domestic product (GDP) benefited more than higher-income countries.⁵²

• – Monitoring tools that track vaccine coverage are valuable in guiding geographically equitable distribution strategies.⁵³ Strengthening public health systems, including the development of national regulatory authorities and independent scientific advisory committees, is also critical.⁵⁴ Furthermore, implementation research can help adapt interventions to local contexts, ensuring that supply chains are equitable and that vulnerable populations have reliable access to vaccines.⁵⁵

Structural innovations in vaccine policy and delivery

Structural innovations aimed at improving governance, equity in access, and the management of misinformation are also crucial to address the deeper, institutional roots of vaccine skepticism. These approaches broaden the perspective from individual psychology to systemic reforms, offering concrete strategies that policymakers and public health systems can adopt.

One promising area involves the use of artificial intelligence (AI) and machine learning (ML) to monitor and respond to misinformation in real time. Tools like LSTM networks and transformer-based models such as COVID-Twitter-BERT have proven highly accurate up to 86% in identifying vaccine-hesitant content on social media platforms, making it possible to intervene more strategically and at scale.^56,57 When combined with educational technologies like virtual simulations and fake news detection training, these innovations help tailor communication to specific populations and reduce the spread of false narratives.⁵⁸

Improving the credibility of vaccine recommendations also means rethinking governance. Reforming advisory bodies like the Advisory Committee on Immunization Practices (ACIP or CAPI´s in Spanish) to include more transparent, evidence-based, and inclusive processes, bringing in recognized and scientifically proven voices from community organizations, healthcare workers, and civil society in order to reduce perceptions of bias and rebuild public trust.⁵⁵ These reforms reflect broader calls for cross-sector collaboration, community feedback mechanisms, and safeguards against conflicts of interest.^59,60

Equally important are community-led models of vaccine delivery, which have shown strong results during the COVID-19 response. In the U.S., mobile clinics successfully reached uninsured and minority populations with over 12,000 vaccine doses administered in just one state.⁶¹ In Middle and lower-income and humanitarian settings, involving trusted local leaders as well as the private sector improve have proven key to improving vaccine uptake and addressing cultural and logistical barriers.⁶²

Finally, policy innovations such as conditional cash transfers (CCTs) and mandatory transparency in pharmaceutical contracting offer additional tools to address structural drivers of hesitancy. In Nigeria, CCT programs have doubled full immunization rates at just $11 per child, and similar initiatives in Kenya and Ghana have boosted uptake by up to 49.5% points when paired with reminders.^63,64 Transparency in licensing, pricing, and intellectual property has also contributed to public confidence, particularly when such measures are clearly communicated and publicly accessible.⁶⁵

Together, these structural innovations move the field beyond individual behavior change and toward systemic resilience. Implementing them effectively requires coordination across sectors and continuous evaluation, but they represent some of the most promising strategies to navigate the complex challenges of vaccine hesitancy in the post-pandemic era.⁶⁶

Conclusion

The COVID-19 pandemic has reshaped public perception of vaccines, creating a paradox where the importance of immunization has never been clearer, yet hesitancy remains pervasive. The rise of the antivaccine movement post pandemic poses significant challenges to achieving herd immunity and controlling infectious diseases.

Addressing this crisis demands a multi-faceted, culturally sensitive approach that prioritizes trust, transparency, and community engagement. Misinformation must be confronted head-on, and public health efforts must adopt innovative, inclusive, and proactive communication strategies. By learning from the lessons of the pandemic, we can restore confidence in vaccines and safeguard future generations from preventable diseases.

Biography

Esteban Ortiz-Prado is a physician, global health researcher, and professor of medicine at the Universidad de las Américas (UDLA) in Quito, Ecuador. He currently serves as Director of the One Health Research Group and has authored over 150 peer-reviewed scientific publications. His research interests focus on high-altitude physiology, epidemiology of infectious diseases, public health policy, and planetary health. Dr. Ortiz-Prado has led national and international collaborative projects on COVID-19 surveillance, zoonotic disease prevention, and health risk assessment in vulnerable populations. He has served as a technical advisor to the Ecuadorian Ministry of Health and international agencies on topics related to pandemic preparedness and environmental health.

Funding Statement

The author(s) reported there is no funding associated with the work featured in this article.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study are available from the corresponding author, [EOP], upon reasonable request.

Ethical considerations

This study was based entirely on secondary data obtained from official institutions, ensuring confidentiality and compliance with ethical standards for research.